The Effect of GLP-1 Receptor Agonist on Cerebral Blood Flow Velocity in Stroke

NCT02829502 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Ischemic Stroke

Interventions

DRUG: Byetta
DRUG: Normosaline

Sponsor

Christina Kruuse